Close

Cellect Biotechnology (APOP) Reports Positive Results from 20 Patients Trial with Tel-Aviv Ichilov Medical Center

October 25, 2017 7:22 AM EDT Send to a Friend
Cellect Biotechnology Ltd. (NASDAQ: APOP) announced today that it has achieved a major milestone with the conclusion of a large ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login